Helix Biopharma Corp. Enters into Asset Purchase Agreement to Acquire Oral Gemcitabine Chemotherapy Compound
The acquistion forms part of an ambitious, yet pragmatic strategy to create a near future where hard-to-treat cancers are less hard-to-treat Helix Biopharma Corp. (TSX:HBP) TORONTO, ONTARIO, CANADA, December 2, 2024 /EINPresswire.com/ -- Helix …